Compared to pre-placebo and statin treatment SLE plasma, post-placebo and statin treatment SLE plasma upregulated the LDL receptor and suppressed both ABCA1 and ABCG1 in THP-1 macrophages. Here, ABCG1 is linked to systemic lupus erythematosus.